Regeneron Pharmaceuticals (REGN) Net Cash Flow (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -124.91% |
| Dec 31, 2025 | 22.70% |
| Sep 30, 2025 | 146.20% |
| Jun 30, 2025 | -278.62% |
| Mar 31, 2025 | 26.26% |
| Dec 31, 2024 | 477.17% |
| Sep 30, 2024 | 112.15% |
| Jun 30, 2024 | -434.35% |
| Mar 31, 2024 | -122.08% |
| Dec 31, 2023 | 174.04% |
| Sep 30, 2023 | 110.65% |
| Jun 30, 2023 | -344.47% |
| Mar 31, 2023 | 310.02% |
| Dec 31, 2022 | -500.62% |
| Sep 30, 2022 | 94.74% |
| Jun 30, 2022 | -89.29% |
| Mar 31, 2022 | 184.33% |
| Dec 31, 2021 | -140.20% |
| Sep 30, 2021 | 114.44% |
| Jun 30, 2021 | 183.80% |
| Mar 31, 2021 | -221.94% |
| Dec 31, 2020 | 248.46% |
| Sep 30, 2020 | -93.56% |
| Jun 30, 2020 | -136.59% |
| Mar 31, 2020 | 153.39% |
| Dec 31, 2019 | -31.33% |
| Sep 30, 2019 | 151.18% |
| Jun 30, 2019 | -375.33% |
| Mar 31, 2019 | -36.61% |
| Dec 31, 2018 | 123.60% |
| Sep 30, 2018 | 267.22% |
| Jun 30, 2018 | -149.13% |
| Mar 31, 2018 | 902.04% |
| Dec 31, 2017 | -56.78% |
| Sep 30, 2017 | 170.79% |
| Jun 30, 2017 | -124.39% |
| Mar 31, 2017 | 174.22% |
| Dec 31, 2016 | -236.08% |
| Sep 30, 2016 | 547.49% |
| Jun 30, 2016 | 120.64% |
| Mar 31, 2016 | -232.60% |
| Dec 31, 2015 | -41.48% |
| Sep 30, 2015 | 324.99% |
| Jun 30, 2015 | 16.66% |
| Mar 31, 2015 | -6,604.02% |
| Dec 31, 2014 | -95.34% |
| Sep 30, 2014 | -66.43% |
| Jun 30, 2014 | 287.49% |
| Mar 31, 2014 | -127.07% |
| Dec 31, 2013 | 329.94% |
| Sep 30, 2013 | -158.85% |
| Jun 30, 2013 | 503.32% |
| Mar 31, 2013 | -144.86% |
| Dec 31, 2012 | 310.18% |
| Sep 30, 2012 | 76.22% |
| Jun 30, 2012 | -150.09% |
| Mar 31, 2012 | -132.11% |
| Dec 31, 2011 | 678.53% |
| Sep 30, 2011 | -140.29% |
| Jun 30, 2011 | 421.56% |
| Mar 31, 2011 | 110.72% |
| Dec 31, 2010 | -199.73% |
| Sep 30, 2010 | 4,115.93% |
| Jun 30, 2010 | 94.08% |
| Mar 31, 2010 | -107.57% |
| Dec 31, 2009 | -104.52% |